Capsulas
Welcome to CAPSULAS, our newsletter in which, since 1997, we have been informing clients and friends about novelties of interest in the area of pharmaceutical law in Spain and in the European Union.
The government approves to relax public procurement and corporate governance rules in view of Covid-19
Jordi Faus, Xavier Moliner, Lluís Alcover and Joan Carles Bailach
Capsulas Special Issue
Spanish Government declares State of Emergency. How does this affect companies in the life sciences sector?
Jordi Faus, Lluís Alcover and Joan Carles Bailach
Capsulas Special Issue
Nitrosamines, storms and climate change, coronavirus… What do the law and the courts say on force majeure?
Xavier Moliner, Jordi Faus and Juan Martínez
CAPSULAS Nº 208
The Supreme Court confirms when executives can be sanctioned for the anticompetitive behavior of their companies
Judgment of the Supreme Court of 28 January 2020
Jordi Faus, Lluís Alcover
CAPSULAS Nº 208
Messages on healthcare and pharma by the new Spanish Coalition Government in Spain
The PSOE-Unidas Podemos Coalition Program contains various relevant measures dedicated to healthcare and pharma
Jordi Faus, Joan Carles Bailach
Capsulas Nº 207
Incoterms® 2020
An updated version of the Incoterms of the International Chamber of Commerce (ICC) enters into force
Lluís Alcover, Juan Martínez
Capsulas Nº 207
Transparency of the documents submitted in the context of a marketing authorization application for a medicinal product
Judgments of the European Court of Justice of 20 January 2020, PTC Therapeutics v EMA, Case C-175/18 P; and MSD Animal Health Innovation and others v EMA, Case C-178/18 P
Jordi Faus